Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial.
about
Fecal Microbiota-based Therapeutics for Recurrent Clostridium difficile Infection, Ulcerative Colitis and ObesityInfections in Cancer Patients with Solid Tumors: A Review.A Review of Experimental and Off-Label Therapies for Clostridium difficile InfectionAnalysis of gut microbiota - An ever changing landscape.Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel diseaseFecal Microbiota Transplantation: From Clostridium difficile to Inflammatory Bowel Disease.Fecal microbiota transplantation in metabolic syndrome: History, present and future.Donor Considerations in Fecal Microbiota Transplantation.Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis.Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota TransplantationEffect of antibiotics on bacterial populations: a multi-hierachical selection process.Clinical and immunologic effects of faecal microbiota transplantation in a patient with collagenous colitis.Bezlotoxumab: anti-toxin B monoclonal antibody to prevent recurrence of Clostridium difficile infection.Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection.Fecal Microbiota Transplant from a Rational Stool Donor Improves Hepatic Encephalopathy: A Randomized Clinical Trial.Challenges in fecal donor selection and screening for fecal microbiota transplantation: A review.European consensus conference on faecal microbiota transplantation in clinical practice.Community dynamics drive punctuated engraftment of the fecal microbiome following transplantation using freeze-dried, encapsulated fecal microbiota.Consensus report: faecal microbiota transfer - clinical applications and procedures.Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: A promising treatment approach.Microbiome: A Potential Component in the Origin of Mental Disorders.Antibiotic-Associated Apoptotic Enterocolitis in the Absence of a Defined Pathogen: The Role of Intestinal Microbiota Depletion.Bezlotoxumab: A Novel Agent for the Prevention of Recurrent Clostridium difficile Infection.Editorial: Making Fecal Microbiota Transplantation Easier to Swallow: Freeze-Dried Preparation for Recurrent Clostridium difficile Infections.Reply to Galperine et al and Jansen.Fecal Microbiota Transplantation: Do We Need Harmonization?Oral Vancomycin Followed by Fecal Transplantation Versus Tapering Oral Vancomycin Treatment for Recurrent Clostridium difficile Infection: An Open-Label, Randomized Controlled Trial.Stable engraftment of human microbiota into mice with a single oral gavage following antibiotic conditioning.Clostridium difficile infection: new approaches to prevention, non-antimicrobial treatment, and stewardship.Clinical Practice and Infrastructure Review of Fecal Microbiota Transplantation for Clostridium difficile Infection.Microbiota Replacement Therapies: Innovation in Gastrointestinal Care.The taxonomic composition of the donor intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in therapy refractory ulcerative colitis.Faecal microbiota transplantation: a regulatory hurdle?Extended Screening Costs Associated With Selecting Donors for Fecal Microbiota Transplantation for Treatment of Metabolic Syndrome-Associated Diseases.Cryopreservation of artificial gut microbiota produced with in vitro fermentation technology.Effect of Oral Capsule- vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection: A Randomized Clinical Trial.Improving regulation of microbiota transplants.Fecal Fixation: Fecal Microbiota Transplantation for Clostridium difficile Infection.Ethical Considerations in Microbial Therapeutic Clinical Trials.Diagnosis and management of gastrointestinal complications in adult cancer patients: 2017 updated evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).
P2860
Q28070349-95E6042E-C20F-4380-A506-DAB14A0F3BA5Q30238576-6D44F5A9-3483-4A9D-A282-E4576E86AB16Q30240264-8FBA41C1-FC60-4BAB-85A2-53201636983DQ31152635-4B706741-F4C2-407E-A5FB-47A9BE31A3CCQ33691783-DDDDB148-BD28-45BB-A64C-DFA935CA5B69Q33717111-F257FF6F-BC4F-4DC0-B9DC-53179D6BF194Q33821397-43376ED7-1AC8-4836-9DF3-3727E8E470CFQ36306985-170872AA-E4E8-4AB8-AED7-BA2E32158916Q36404998-607927FF-93A9-415A-AE26-6AB72AA1405AQ37530430-AB60A2ED-9045-4E47-8AA3-F24C2DE24F59Q37595457-2CEA4FF0-8EC9-410F-BF18-6F87AF0DC52EQ37662655-3FF12975-68C9-4EC4-AAED-EB0E7BBA4E78Q38668483-38E2D734-0928-43A9-A0D6-E83D225B090AQ38679612-D963F4AE-3B39-4442-90F9-48EF37272F28Q38740977-F415C67F-E8F9-46CE-B9BD-1B34225ECFB0Q38764998-E5CACEDB-C5F4-4535-9335-F6A7C078AD43Q38770514-7550FAAF-2A00-418C-904E-08470BD6E993Q38914938-8BC3B081-310C-4595-8F04-E616A6644D9CQ39021811-647E0EBA-5663-413D-8AA4-F8B4DDF05AA1Q39077926-79A97C30-B3E3-49B8-B78F-F00C63E8DF8FQ39388187-97727693-3A3B-4794-B7D7-81C99511D915Q39606031-D97794B0-87B3-4EA1-A477-A9658AEC118AQ40125340-043CD6B6-1E3F-4A05-8300-328EB148F2DCQ40188521-EEFC84A3-0E40-49BE-8294-699FB87F94BDQ40346751-2AAB087F-6692-4DF8-BA96-D1ABFCC95EAFQ40346771-F110C4AC-2FCD-46F5-AA0E-C9ED44701B45Q40397168-2DE9322A-37A9-4AF1-AA0E-AF6B08B91D37Q41195942-4083ED02-FFEB-4043-8222-FEB1853E203CQ41990887-047BCA1C-D605-489E-93E0-55BE8DD6AF3CQ41996759-12BCAD99-884C-4179-965A-85BE450A93D3Q46274429-0FD3410E-5D4C-467F-8090-E82DA83A187CQ46279754-A85E06AC-07B1-4F2D-B50B-28D1A1B8A58BQ47095953-E3C7C1E3-8C25-4347-B05D-1EDFBEC69F48Q47148596-7CA98344-8EC7-4728-944C-67DC26883002Q47341286-D4AE31B7-3654-4887-A8D8-2B853B32959FQ47548289-A5AD2CEA-FE36-444D-BB80-ABC7E06C41B0Q47678524-C8F7C454-4D6F-49FF-808A-E669D06316A5Q48007064-B99141B9-266C-438C-BFB4-95C67575234BQ48176834-23737116-EBE8-4DAB-8560-488C7361B3E9Q49195473-FE0DA238-B8CB-496D-BF80-1D50171D7602
P2860
Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Effect of Fecal Microbiota Tra ...... Infection: A Randomized Trial.
@en
type
label
Effect of Fecal Microbiota Tra ...... Infection: A Randomized Trial.
@en
prefLabel
Effect of Fecal Microbiota Tra ...... Infection: A Randomized Trial.
@en
P2093
P2860
P356
P1476
Effect of Fecal Microbiota Tra ...... Infection: A Randomized Trial.
@en
P2093
Allison Tisch
Brianna Bakow
Christopher Staley
Colleen R Kelly
Jason T Machan
Joyce McKenney
Lawrence J Brandt
Mortadha Abd
Mustafa Alani
Patrizia Curran
P2860
P304
P356
10.7326/M16-0271
P407
P577
2016-08-23T00:00:00Z